Free Trial

Extendicare (TSE:EXE) Upgraded to "Moderate Buy" at Cormark

Extendicare logo with Medical background

Cormark upgraded shares of Extendicare (TSE:EXE - Free Report) to a moderate buy rating in a research note published on Wednesday morning,Zacks.com reports. Cormark also issued estimates for Extendicare's FY2024 earnings at $0.79 EPS, FY2025 earnings at $0.74 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $0.95 EPS.

A number of other brokerages have also recently commented on EXE. TD Securities raised their target price on Extendicare from C$9.50 to C$10.50 and gave the company a "hold" rating in a report on Thursday, November 14th. Royal Bank of Canada raised their target price on Extendicare from C$9.50 to C$11.00 and gave the company a "sector perform" rating in a report on Thursday, November 28th. Finally, BMO Capital Markets set a C$11.00 target price on Extendicare and gave the company a "market perform" rating in a report on Thursday, January 30th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of C$10.25.

Get Our Latest Stock Report on Extendicare

Extendicare Trading Down 0.7 %

Shares of TSE:EXE traded down C$0.08 during midday trading on Wednesday, reaching C$11.45. 314,009 shares of the company's stock were exchanged, compared to its average volume of 150,129. The firm's 50 day simple moving average is C$10.53 and its two-hundred day simple moving average is C$9.60. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. The stock has a market cap of C$955.70 million, a price-to-earnings ratio of 14.60 and a beta of 1.26. Extendicare has a fifty-two week low of C$6.63 and a fifty-two week high of C$11.71.

Extendicare Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be given a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a yield of 4.19%. The ex-dividend date of this dividend is Friday, February 28th. Extendicare's dividend payout ratio (DPR) is 61.20%.

Extendicare Company Profile

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Read More

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines